GSK3B-DT and breast cancer: The results of breast cancer patients with GPNCA expression (FPKM value) ≥ 0.417 were of high-risk leading to poor OS (HR = 1.392, 95% CI, 1.032–1.959, P = 0.0324) (Fig. 3D and Supplemental Fig. S1D).